Life Science Partner recruits Innovative R&D Scientist.
Life Science Partner announces the recruitment of Shubhayu Basu, PhD, formerly Group Lead for New Business Ventures at Abbott Vascular, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio. The organization was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products. GCIC will focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.
In Basu’s former role at Abbott Vascular (formerly Guidant), he was responsible for creating and implementing processes for identifying emerging technologies and various disease spaces and opportunities against the company portfolio and growth landscape. Previously, he served as Group Lead, Research and Development, Cardiac Therapies for the company. Prior to joining Guidant/Abbott, Basu was a Biodesign Innovation Fellow at Stanford University’s Biodesign Program in Palo Alto, CA.
“Basu will join another LSP recruit – Gene Jung – who shares his passion about new technologies and their application in patient care,” noted Tom Callaway, MD, founder and president of Life Science Partner. “His ability to work with complex technologies to identify commercial opportunities and to oversee their development is a perfect fit for the GCIC team.”
Basu earned both his Bachelor and Masters Degree of Technology in Biochemical Engineering and Biotechnology at the Institute of Technology in New Delhi, India. He received his PhD in Chemical Engineering at the Ohio State University in Columbus.